Fulminant hepatitis caused by hepatitis C virus during treatment for multiple sclerosis

被引:10
|
作者
Funaoka, M
Kato, K
Komatsu, M
Ono, T
Hoshino, T
Kato, J
Kuramitsu, T
Ishii, T
Toyoshima, I
Masamune, O
机构
[1] First Dept. of Internal Medicine, Akita University, School of Medicine, Akita, Akita, 010
关键词
fulminant hepatitis; hepatitis C virus; multiple sclerosis;
D O I
10.1007/BF01211198
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A 55-year-old woman was treated at our hospital for multiple sclerosis. Therapy consisted of glucocorticosteroids and cyclosporin. In the 7th week after these drugs were discontinued the patient developed acute liver failure due to fulminant hepatitis (FH) and died. Post-mortem examination showed massive liver necrosis. Serologic examination was negative for hepatitis B virus-related markers. Antihepatitis C virus (anti-HCV) antibody and serum HCV RNA were negative on admission, but HCV RNA appeared concurrently with the onset of FH. Although HCV infection rarely causes FH, it was considered to be the cause of FH in this patient, since there were no other causes of acute liver injury. We suspect that underlying immunologic abnormalities in conjunction with HCV infection may have precipitated the FH.
引用
收藏
页码:119 / 122
页数:4
相关论文
共 50 条
  • [1] Fulminant hepatitis caused by hepatitis C virus
    Taga, T
    Ikeda, M
    Suzuki, K
    Ohta, S
    Hirota, T
    Shimada, M
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (12) : 1174 - 1176
  • [2] Fulminant Hepatitis Associated With Echovirus 25 During Treatment With Ocrelizumab for Multiple Sclerosis
    Nicolini, Laura Ambra
    Canepa, Paola
    Caligiuri, Patrizia
    Mikulska, Malgorzata
    Novi, Giovanni
    Viscoli, Claudio
    Uccelli, Antonio
    JAMA NEUROLOGY, 2019, 76 (07) : 866 - 867
  • [3] HEPATITIS-C VIRUS AND FULMINANT-HEPATITIS
    MOSLEY, JW
    RAKELA, J
    ANNALS OF INTERNAL MEDICINE, 1991, 115 (12) : 983 - 984
  • [4] Hepatitis C virus (HCV) reactivation during fingolimod treatment for relapsing and remitting multiple sclerosis
    Tagawa, Asako
    Ogawa, Tomoko
    Tetsuka, Syuichi
    Otsuka, Mieko
    Hashimoto, Ritsuo
    Kato, Hiroyuki
    Ando, Katsuyoshi
    Tanabe, Hiroki
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 9 : 155 - 157
  • [5] GENOTYPE OF HEPATITIS-C VIRUS IN FULMINANT-HEPATITIS-C
    YOSHIBA, M
    SEKIYAMA, K
    INOUE, K
    SUGATA, F
    OKAMOTO, H
    DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (01) : 220 - 221
  • [6] ACUTE FULMINANT NON-A, NON-B HEPATITIS IS NOT CAUSED BY THE HEPATITIS-C VIRUS
    HSU, HH
    WRIGHT, TL
    LAKE, JR
    FEINSTONE, SM
    GREENBERG, HB
    CLINICAL RESEARCH, 1991, 39 (01): : A27 - A27
  • [7] Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus
    Vento, S
    Cainelli, F
    Mirandola, F
    Cosco, L
    DiPerri, G
    Solbiati, M
    Ferraro, T
    Concia, E
    LANCET, 1996, 347 (8994): : 92 - 93
  • [8] The hepatitis C virus is an important etiologic factor in fulminant hepatitis
    Sergi, C
    Jundt, K
    Goser, T
    Otto, G
    Otto, HF
    Hofmann, WJ
    GASTROENTEROLOGY, 1996, 110 (04) : A1319 - A1319
  • [9] Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C
    Vento, S
    Garofano, T
    Renzini, C
    Cainelli, F
    Casali, F
    Ghironzi, G
    Ferraro, T
    Concia, E
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (05): : 286 - 290
  • [10] FULMINANT HEPATITIS DURING TREATMENT WITH PROPYLTHIOURACIL
    EISEN, MJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1953, 249 (20): : 814 - 816